|
original article |
Journal |
Date |
Title |
Authors Max. 6 Authors |
1 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2024―Jul―03 |
Evaluation of the Real-World Effectiveness of Traditional Chinese Medicine in Treating Coronavirus Disease-2019 |
Yajie Liu, Rumei Xiang, Jinliang Yang, Jiaheng Shi, Yaoyue Hu, Lianguo Ruan, Tao Bai, Jiaqi Chai, Xinghua Xiang, Mimi Xiao, Jingyu Zhang, Wei Xu, Hui Zhao, Jie Liu, Yang Yang, Qiuling Shi |
2 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2024―Feb―21 |
In Silico Analysis of Siddha Formulation Thippili Rasayanam Against COVID-19 in Inhibition of Ribonucleic Acid-Dependent Ribonucleic Acid Polymerase Target Enzyme |
S. M. Chitra |
3 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Dec―07 |
Efficacy and Direct Medical Costs of Metformin-Glibenclamide Treatment in Ecuadorian Population with Type II Diabetes Mellitus during the COVID-19 Pandemic |
R. Zambrano, Maria Del Carmen Cabezas, G. Loor, Nicole Aguirre, Camila Mino |
4 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Sep―11 |
Development and Validation of Favipiravir Severe Acute Respiratory Syndrome Coronavirus 2 Drug by Dissolution Method with Filter Compatibility Study |
S. Kanithi, N. S. S. P. K. Chebolu, G. N. Challa |
5 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Mar―17 |
Immunological Response to Conventional COVID-19 Vaccines in a Cohort of Pakistani Healthy Recipients |
Rajaa Mohammad Al-Raddadi, A. Rehman, Sadia Farhad, T. A. Khan, Sumera Sumera, A. M. Hashem, E. I. Azhar, M. Almuhayawi, T. S. Abujamel, Jawahir Ahmad Mokhtar, H. A. Niyazi, T. Alamri, S. Harakeh, Y. M. Yousafzai |
6 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Feb―27 |
Molecular Docking study of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein with Celastroid Triterpenoid Inhibitors |
Bhaskar Bagchi, Tamal Goswami |
7 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Jan―27 |
Potential Mechanism of Colchicine against COVID-19 and Non-Small Cell Lung Cancer based on Network Pharmacology and Bioinformatics Analysis |
Zhiyao Liu, Hailiang Huang, Ying Yu, Yuqi Jia, Lingling Li, Xin Shi, Fangqi Wang |
8 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Jan―27 |
Retrospective Analysis of Neutralizing Antibody Cocktail (Casirivimab and Imdevimab): A Game Changer in Treating Mild COVID-19 Patients |
Anu Gaikwad, Vini Mehta, Chirali Shah, Mansi Agrawal, R. A. Shaik, Mashael B. Alharbi, M. Alrouji, S. Alhajlah, O. Alomeir, Ritu Kumar Ahmad, M. S. Ahmad, F. H. Alanazi, A. Alharbi, A. Tawakul, M. T. Hemdi, K. K. Aldossari, R. Aldahash |
9 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2023―Jan―05 |
An Overview of the Approaches for the Pharmacotherapy of Pandemic Causing Coronaviruses of the 21st Century |
Prachi Prajapati, S. Singh, K. R. Iyer |
10 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Nov―16 |
Plasma Therapy: An Effective Treatment for Infections from Microbes with Special Reference to Coronavirus Disease 2019 |
Shivani Sainani, D. Bhombe, Ketki Rode, A. Deshmukh, Shivani Desai |
11 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Nov―16 |
Inhibitory Potentials of Phytoconstituents of Phyllanthus amarus against Severe Acute Respiratory Syndrome-Corona Virus-2 Main Protease: A Computational Aided Approach |
M. Pushpa Sree, G. Prakash Yoganandam, V. Gopal |
12 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Jul―13 |
Phytochemicals: A Novel Approach for the Management of Coronavirus Disease 2019 |
R. S. Shivatare, R. Musale, N. K. Bhutale, S. M. Kewatkar, H. L. Tare, Vibhavari Chatur, A. N. Khatawakar, D. S. Suryavanshi |
13 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Jul―13 |
An Integrated Strategy Designed To Explore the Common and Diverging Mechanisms of Potential Drugs against the Novel Coronavirus Pneumonia Based on Network Pharmacology and In Silico Molecular Docking Technology |
Q. Zhao, G. H. Li, B. Zheng, P. Feng, P. Wang, X. Li |
14 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―18 |
The Effect of Ivermectin on Reducing Viral Symptoms in Patients with Mild COVID-19 |
K. U. Abbas, S. Muhammad, S. F. Ding |
15 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―18 |
Convalescent Plasma Therapy: A Treatment of Choice for COVID-19 during Current Pandemic |
T. M. Yunus Khan, I. A. Badruddin, S. A. Saquib, R. Mohamed, S. Arora, M. A. K. Mohammed, S. V. Shamsuddin, S. Khateeb, A. A. Khan, V. Grover, Priyanka Saluja |
16 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―18 |
Attitudes and Belief among the Population in Saudi Arabia about the Consumption of Herbal Products for the Prevention of COVID-19 Infection: A Cross-Sectional Study |
Afaf Aldahish, Mona Almanasef, Nouf Al-Saad, Reem Asiri, Rajalakshimi Vasudevan, Geetha Kandasamy |
17 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2022―Mar―07 |
Virtual Screening of Anti Severe Acute Respiratory Syndrome Coronavirus 2 Drugs Targeting Main Protease |
Hui Mao, Chunxia Chu, Xianyue Hu, Yue Yuan |
18 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Dec―17 |
The Preparedness of Emergency Medical Services Students for Coronavirus Disease 2019: A Cross-Sectional Study among Paramedic Students |
D. M. Al Razeeni, A. Al-Wathinani, R. Alhazmi, O. A. Samarkandi, S. A. Ronal, Basma Salameh, A. Alenazi |
19 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Dec―07 |
Potential of Bacteriophage Therapy: A Double Edge Sword to Combat COVID-19 and Associated Pulmonary Bacterial Infections |
Kanika Bhargava, G. Nath, G. K. Aseri, Neelam Jain |
20 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Dec―07 |
Identification of Compounds from Curcuma longa with In Silico Binding Potential against SARS-CoV-2 and Human Host Proteins Involve in Virus Entry and Pathogenesis |
S. Kumar, A. K. Singh, P. P. Kushwaha, Kumari Sunita Prajapati, S. Senapati, S. Mohd Mohd, S. Gupta |
21 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Nov―09 |
Insights into Molecular Mechanisms Underlying COVID-19 Pathogenesis and Potential Therapeutics |
Shravanthi Ravula, Sai Charitha Mullaguri, Sravani Akula, R. Silveri, R. K. Kancha |
22 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Aug―04 |
Clinical Characteristics of Nutritional Indicators in Patients with Covid-19 |
Bo Yuan Zhang, Y. T. Sun, H. Pan, Li Zhang |
23 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―Jul―03 |
In silico Studies Predict Efficient Binding of Remdesivir and Favipiravir with 3-chymotrypsin like protease of SARS-CoV-2 for COVID-19 Interventional Therapy |
D. Dey, N. Dey, Shalini Ghosh, Padma Thiagarajan |
24 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―14 |
Discussion on the Correlation between Clinical Typing of Covid-19 Patients and Risk Factors and Peripheral Red Blood Cell Parameters |
LI ZHANG, L. X. WANG, J. Y. ZHAO, Y. S. WANG, Y. T. SUN |
25 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―14 |
Construction of Novel Coronavirus Pneumonia Emergency Management System Based on Multi Agent Cooperation Mechanism |
J. F. SHANG |
26 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―11 |
In silico Multi Subunit Vaccine Design Referring Spike Glycoprotein of SARS-COV-2 (COVID-19): The World Pandemic |
ANKUR BHARDWAJ |
27 |
[GO] |
Indian Journal of Pharmaceutical Sciences |
2021―May―11 |
The Difficulties, Opportunities and Challenges of Covid-19 by Chinese Medicine on China |
XUANXUAN WANG, HUA LI, PING WANG, XUN GONG, GUANGJIE LI, ZHENCHUAN JIANG, JIAO CHEN, GUO LU, HONGPING CHENG, ZHENG WANG, XIAOWEI. WU |